Industry: Cold Chain & Healthcare Logistics (Logistics & Supply Chain)
Source: https://www.mordorintelligence.com/industry-reports/europe-pharmaceutical-cold-chain-logistics-market
Scraped Date: 2026-09-17
| Market Metric | Details |
|---|---|
| Base Market Size | USD 22.58 billion |
| Projected Forecast (2031) | USD 22.58 billion |
| Growth Rate (CAGR) | 4.59 % |
| Largest Market Region | N/A |
| Fastest-Growing Region | N/A |
!Major players in Europe Pharmaceutical Cold Chain Logistics industry
!Europe Pharmaceutical Cold Chain Logistics Market Size
!Europe Pharmaceutical Cold Chain Logistics Market Share by Services, 2025
!Europe Pharmaceutical Cold Chain Logistics Market Share by Product, 2025
!Europe Pharmaceutical Cold Chain Logistics Market Concentration
!Icon
!Vijeron Intelligence on Facebook
!Vijeron Intelligence on Pinterest
!Vijeron Intelligence on Instagram
!GPTW
Market Overview
Study Period | 2020 - 2031 |
Forecast Data Period | 2026 - 2031 |
Base Year Market Size (2025) | USD 21.5 Billion |
Market Size (2026) | USD 22.58 Billion |
Market Size (2031) | USD 28.26 Billion |
Growth Rate (2026 - 2031) | 4.59 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
|
Europe Pharmaceutical Cold Chain Logistics Market Analysis by Vijeron IntelligenceThe Europe pharmaceutical cold chain logistics market size is projected to expand from USD 21.50 billion in 2025 and USD 22.58 billion in 2026 to USD 28.26 billion by 2031, registering a CAGR of 4.59% between 2026 and 2031.
Demand grows as maternal immunization and respiratory syncytial virus vaccine roll-outs transform year-round distribution patterns, while cell and gene therapy approvals push requirements for ultra-low temperature handling. Serialization mandates under EU legislation elevate the need for value-added tracking and relabelling, and the EU Corporate Sustainability Reporting Directive spurs a shift toward reusable passive packaging that rewards providers with capital for green investments. At the same time, the F-gas phase-down obliges operators to phase out hydrofluorocarbon systems, tilting competitive advantage to firms able to finance natural-refrigerant retrofits. Automation, robotics, and IoT visibility tools drive productivity gains, but growing cyber-risks demand hardened digital infrastructure across the entire Europe pharmaceutical cold chain logistics market.
Key Report Takeaways
Europe Pharmaceutical Cold Chain Logistics Market Trends and InsightsDrivers Impact Analysis*
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
Surge in RSV and maternal vaccine launches | +0.9% | EU-wide, led by Germany, France, United Kingdom, Spain | Medium term (2-4 years) |
Expansion of specialty pharmacy and home infusion networks | +0.7% | Nordic countries, Netherlands, Germany, United Kingdom | Medium term (2-4 years) |
Investment boom in automated cold warehouses and robotics | +0.8% | Germany, Netherlands, Belgium, France | Long term (≥ 4 years) |
Cross-border Brexit corridor relabelling hubs | +0.5% | Netherlands, Belgium, Ireland, France | Short term (≤ 2 years) |
EU-CSRD push toward reusable passive packaging | +0.4% | EU-wide, led by Germany, Netherlands, Nordic countries | Long term (≥ 4 years) |
Near-shoring of API and fill-finish to Central-Eastern Europe | +0.6% | Poland, Czech Republic, Hungary, Romania | Long term (≥ 4 years) |
Source: Vijeron Intelligence |
Competitive Landscape
DHL Supply Chain, Kuehne + Nagel, and UPS head the field with continent-wide GDP networks and capital to automate warehouses. DHL’s EUR 2 billion (USD 2.35 billion) program adds Pharma Hubs equipped for multi-temperature docking and AI route optimization. UPS strengthened European reach via the CAD 2.2 billion (USD 1.60 billion) acquisition of Andlauer Healthcare in 2025.
Regional specialists like Movianto and Trans-o-flex capture therapeutic niches, leveraging bespoke packaging and last-mile fleets to differentiate. Cold Chain Technologies’ energy-positive shipper plant in Breda aligns with EU-CSRD goals, appealing to sustainability-focused tenders. F-gas compliance accelerates consolidation, as retrofits exceed EUR 5 million (USD 5.88 million) for mid-sized depots, unaffordable for some independents.
Technological rivalry intensifies around IoT telemetry, blockchain traceability, and warehouse robotics. Cyber-risk resilience becomes a selling point after the 2024 ransomware incident that froze customer portals. Providers offering end-to-end dashboards and 24/7 security operations command premium pricing, reinforcing a moderate-to-high concentration structure for the Europe pharmaceutical cold chain logistics market.
Europe Pharmaceutical Cold Chain Logistics Industry Leaders* DHL Group
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
Europe Pharmaceutical Cold Chain Logistics Market Report ScopeBy ServicesTransportation | Road |
| Air |
|---|
| Sea |
| Rail |
Warehousing and Distribution |
Value-added Services and Others |
By CountryGermany |
United Kingdom |
France |
Italy |
Spain |
Netherlands |
Belgium |
Poland |
Sweden |
Rest of Europe |
The market is projected to expand at a 4.59% CAGR over 2026-2031.
Value-added services, covering serialization and real-time monitoring, are forecast to register a 5.27% CAGR.
Post-Brexit relabelling demand and new A+++ cold-chain campuses are driving a 5.70% CAGR outlook for the Netherlands.
Operators must replace HFC systems with natural refrigerants, lifting capital expenditure and favoring well-capitalized firms.
Deep-frozen and ultra-low logistics for cell and gene therapies are set to rise at a 5.61% CAGR.
Biotech and biosimilar manufacturers, growing at a 6.27% CAGR, will drive new contract wins for specialized providers.